Asociación para Evitar la Ceguera en México, Mexico City 04030, Mexico.
DBGen Ocular Genomics, 08028 Barcelona, Spain.
Genes (Basel). 2021 Nov 19;12(11):1824. doi: 10.3390/genes12111824.
In this work, we aimed to provide the genetic diagnosis of a large cohort of patients affected with inherited retinal dystrophies (IRDs) from Mexico. Our data add valuable information to the genetic portrait in rare ocular diseases of Mesoamerican populations, which are mostly under-represented in genetic studies. A cohort of 144 unrelated probands with a clinical diagnosis of IRD were analyzed by next-generation sequencing using target gene panels (overall including 346 genes and 65 intronic sequences). Four unsolved cases were analyzed by whole-exome sequencing (WES). The pathogenicity of new variants was assessed by in silico prediction algorithms and classified following the American College of Medical Genetics and Genomics (ACMG) guidelines. Pathogenic or likely pathogenic variants were identified in 105 probands, with a final diagnostic yield of 72.9%; 17 cases (11.8%) were partially solved. Eighteen patients were clinically reclassified after a genetic diagnostic test (17.1%). In our Mexican cohort, mutations in 48 genes were found, with , and as the major contributors. Notably, over 50 new putatively pathogenic variants were identified. Our data highlight cases with relevant clinical and genetic features due to mutations in the and genes, enrich the novel mutation repertoire and expand the IRD landscape of the Mexican population.
在这项工作中,我们旨在为来自墨西哥的遗传性视网膜疾病(IRDs)患者大队列提供基因诊断。我们的数据为中美洲人群罕见眼部疾病的遗传特征增添了有价值的信息,而这些人群在遗传研究中大多代表性不足。通过使用靶向基因panel(总共包括 346 个基因和 65 个内含子序列)对 144 名无亲缘关系的临床诊断为 IRD 的先证者进行了下一代测序分析。对四个未解决的病例进行了全外显子组测序(WES)分析。通过计算预测算法评估新变体的致病性,并根据美国医学遗传学与基因组学学院(ACMG)指南进行分类。在 105 名先证者中发现了致病性或可能致病性的变异,最终诊断率为 72.9%;17 例(11.8%)部分解决。18 名患者在基因诊断测试后进行了临床重新分类(17.1%)。在我们的墨西哥队列中,发现了 48 个基因中的突变,其中 、 和 是主要贡献者。值得注意的是,确定了 50 多个新的疑似致病性变体。我们的数据突出了因 和 基因突变而具有相关临床和遗传特征的病例,丰富了新的突变谱,并扩展了墨西哥人群的 IRD 图谱。